Live Breaking News & Updates on Agios Pharmaceuticals

Stay updated with breaking news from Agios pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Agios Pharmaceuticals (NASDAQ:AGIO) Rating Increased to Hold at StockNews.com

StockNews.com upgraded shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) from a sell rating to a hold rating in a research note issued to investors on Wednesday. Several other analysts also recently weighed in on AGIO. Royal Bank of Canada reduced their target price on Agios Pharmaceuticals from $43.00 to $42.00 and set an outperform […] ....

United-states , Canada , Jacqualyna-fouse , James-william-burns , Frazier-life-sciences-management , Norges-bank , Goldman-sachs-group , Royal-bank , Jpmorgan-chase-co , Agios-pharmaceuticals-inc , News-ratings-for-agios-pharmaceuticals-daily , Agios-pharmaceuticals-stock-down

Leerink Partnrs Comments on Agios Pharmaceuticals, Inc.'s Q4 2024 Earnings (NASDAQ:AGIO)

Leerink Partnrs Comments on Agios Pharmaceuticals, Inc.'s Q4 2024 Earnings (NASDAQ:AGIO)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada , China , United-states , James-william-burns , Jacqualyna-fouse , Leerink-partnrs , Zurcher-kantonalbank-zurich-cantonalbank , Investment-management , Agios-pharmaceuticals , Cantor-fitzgerald , News-ratings-for-agios-pharmaceuticals-daily , Nasdaq

Royalty Pharma : Vorasidenib Transaction Call Transcript

REFINITIV STREETEVENTS

EDITED TRANSCRIPT

RPRX.OQ - Royalty Pharma PLC To Host Investor Call

. ....

United-states , America , Michael-difiore-evercore , Terence-flynn-morgan-stanley , Michael-difiore , Terry-coyne , Pablo-legorreta , Geoff-meacham , Terence-flynn , George-grofik , Marshall-urist , Research-investments

Agios sells vorasidenib royalty rights to Royalty Pharma for $905M

Vorasidenib, which treats IDH-mutant diffuse glioma, showed efficacy in data released last year. ....

Brian-goff , Pablo-legorreta , Drug-administration , Agios-pharmaceuticals , Royalty-pharma , Prescription-drug-user-fee-act ,

Agios Stock Poised To Break Out On $905 Million Brain Cancer Deal

Agios agreed Tuesday to sell its 15% royalty in a brain cancer drug for $905 million upfront. Agios stock broke out at the open. ....

Brian-goff , Agios-pharmaceuticals , Drug-administration , Royalty-pharma , Chief-executive-brian-goff ,